Ads
related to: top doctors for prostate cancer specialist- Need a Second Opinion?
Put Our Expertise to Work for You.
Get a Virtual Second Opinion Today.
- Prostate Cancer Treatment
Download our Prostate Cancer Guide
Find Prostate Cancer Treatments
- Schedule an Appointment
Schedule an Appointment Today
Call our Cancer Answer Line
- Virtual Second Opinions
Get Peace of Mind from Home.
Review Your Diagnosis & Treatment.
- Need a Second Opinion?
Search results
Results from the WOW.Com Content Network
Mark Scholz (born 1955) is a German-American, double board-certified oncologist and author. He serves as medical director of Prostate Oncology Specialists Inc. in Marina del Rey, CA, a medical practice exclusively focused on prostate cancer.
Mark Emberton OBE is a urologist and prostate cancer research specialist using novel imaging techniques and minimally invasive treatments to improve diagnosis and treatment of prostate cancer. Emberton is Professor of Interventional oncology at University College London and Dean of its Faculty of Medical Sciences.
Previously he served as director of the Lefrak Institute of Robotic Surgery, director of prostate cancer, as well as the director of robotic prostatectomy and prostate cancer-urologic oncology outcomes at the Brady Urology Foundation of Weill Medical College. [19] He is a tenured professor of urology at the Icahn School of Medicine at Mount Sinai.
Getting regular screenings and check-ups, knowing your risk factors for prostate cancer, and communicating with your doctor can help catch the disease early so you can get treated, Dr. Spratt says.
Prostate cancer is the second most common cause of cancer death among men, according to the American Cancer Society. This year, the organization projects that about 300,000 new cases will be ...
Slawin is a co-discoverer of -2proPSA (P2PSA), [8] [9] a molecular form of prostate specific antigen, which has been shown to improve the accuracy of prostate cancer screening. [10] A multi-center study supported by the National Cancer Institute verified the ability of proPSA to be a valid marker for early detection of prostate cancer. [11]
He has published extensively on both prostate cancer translational studies and clinical trials that involve novel agents. [10] Sartor was the PI or co-PI on four prostate cancer studies pivotal for FDA drug approval including Samarium-153 EDTMP, [11] Cabazitaxel, [12] Radium-223, [13] and Leuprolide Acetate 30 mg sustained release . [14]
Prostate cancer is one of the most common types of cancer in men, ranking only behind lung cancer in deaths. About 1 in 8 men will be diagnosed with prostate cancer during their lives, according ...
Ads
related to: top doctors for prostate cancer specialist